Back

Identification of Pseudomonas aeruginosa genetic determinants that connect redox metabolism to alginate biosynthesis

Kim, S.-K.; Thamban Chandrika, N.; Belew, A. T.; El-Sayed, N. M.; Garneau-Tsodikova, S.; Lee, V. T.

2026-02-06 microbiology
10.64898/2026.02.05.704140 bioRxiv
Show abstract

Pseudomonas aeruginosa is a well-known human pathogen that contributes significantly to chronic infections, particularly in cystic fibrosis (CF) patients. During this chronic infection, P. aeruginosa undergoes a phenotype change, the inactivation of mucA, which leads to the production of exopolysaccharide alginate, known as mucoid, a key virulence factor associated with biofilm formation. This mucoid phenotype allows the bacterium to persist in the lungs of CF patients for the duration of their lives. Previously, we identified ebselen oxide (EbO) as an inhibitor that suppresses alginate production in P. aeruginosa. In the current study, we synthesized a series of structural analogs based on EbO and ebselen (Eb) and evaluated their ability to inhibit alginate production. These analogs did have similar or lower inhibitory activity than EbO. The mechanism by which EbO inhibits alginate production remains unclear. We employed RNA sequencing analysis of P. aeruginosa treated with inhibitors and identified several candidate genes potentially involved in this inhibitory pathway. Interestingly, we observed that a transposon and in-frame deletion mutants of the candidate genes were defective for alginate production. These findings suggest there are additional requirements for optimal alginate production in conditions that mimic the CF lung beyond the algD-A operon. IMPORTANCEWhen bacteria encounter the correct conditions, they can dedicate their energy toward a specific function to maximize the function. One example is the low calcium response in Yersinia pestis in which the bacteria arrest growth when grown at 37 {degrees}C in the absence of calcium because it uses all its energy for type III secretion. Another example is production of alginate by P. aeruginosa in the lungs of CF patients that can lead to occlusion of the airways. In both cases, the dedicated use of energy toward type III secretion for Y. pestis and alginate biosynthesis for P. aeruginosa reduces the ability of the bacteria to multiply. In the lab, suppressors can be easily identified that restore bacteria growth. The suppressor mutations are often located in the operons that are up-regulated and thereby prevent the execution of the energetically costly process. While these results indicate these processes are energetically costly, we still do not understand how the bacteria dedicate their energy toward these processes over other cellular processes such as growth. Previously, we identified ebselen oxide (EbO) as an inhibitor that suppresses alginate production in P. aeruginosa, but chemical analogues fail to improve the inhibitory activity. We used RNA sequencing analysis of P. aeruginosa treated with inhibitors and identified several candidate genes potentially involved in this inhibitory pathway. Interestingly, we observed that a transposon and in-frame deletion mutants of these genes involved in redox reactions were defective for alginate production. These findings suggest there proteins may shunt energy for optimal alginate production in conditions that mimic the CF lung beyond the algD-A operon. Results from P. aeruginosa alginate production may inform how other bacteria can similarly focus energy toward specific cellular processes.

Matching journals

The top 2 journals account for 50% of the predicted probability mass.

1
Journal of Bacteriology
190 papers in training set
Top 0.1%
41.4%
2
mBio
750 papers in training set
Top 0.8%
15.4%
50% of probability mass above
3
mSphere
281 papers in training set
Top 0.5%
6.7%
4
Microbiology
57 papers in training set
Top 0.3%
3.2%
5
PLOS Genetics
756 papers in training set
Top 6%
2.9%
6
Microbiology Spectrum
435 papers in training set
Top 2%
2.0%
7
PLOS ONE
4510 papers in training set
Top 58%
1.4%
8
Applied and Environmental Microbiology
301 papers in training set
Top 2%
1.3%
9
Scientific Reports
3102 papers in training set
Top 65%
1.3%
10
Molecular Biology of the Cell
272 papers in training set
Top 2%
1.0%
11
PLOS Biology
408 papers in training set
Top 16%
0.9%
12
Journal of Cystic Fibrosis
15 papers in training set
Top 0.2%
0.8%
13
PLOS Pathogens
721 papers in training set
Top 8%
0.8%
14
Frontiers in Cellular and Infection Microbiology
98 papers in training set
Top 5%
0.8%
15
mSystems
361 papers in training set
Top 7%
0.8%
16
Journal of Biological Chemistry
641 papers in training set
Top 4%
0.8%
17
Disease Models & Mechanisms
119 papers in training set
Top 3%
0.8%
18
PLOS Computational Biology
1633 papers in training set
Top 24%
0.8%
19
Molecular Microbiology
66 papers in training set
Top 0.9%
0.8%
20
iScience
1063 papers in training set
Top 31%
0.8%
21
Investigative Opthalmology & Visual Science
37 papers in training set
Top 0.6%
0.8%
22
eLife
5422 papers in training set
Top 60%
0.7%
23
Antimicrobial Agents and Chemotherapy
167 papers in training set
Top 2%
0.7%
24
MicrobiologyOpen
18 papers in training set
Top 0.3%
0.5%
25
Environmental Microbiology
119 papers in training set
Top 3%
0.5%